FILTER

FILTERED INTERVIEW RESULTS

Peter DeYoung

CEO, PIRAMAL PHARMA SOLUTIONS
Piramal Pharma Solutions comments on its continued global expansion.

Manni Kantipudi & Ramesh Subramanian

CHIEF EXECUTIVE OFFICER (CEO) AND CHIEF COMMERCIAL OFFICER (CCO), ARAGEN LIFE SCIENCES
Aragen Life Sciences explains how its expansion in both India and US can benefit drug discovery companies.

Robert Bloder

CHIEF BUSINESS OFFICER, ASCENDIA PHARMACEUTICALS
"We were excited to secure equity investment from Signet Healthcare Partners and have since almost doubled in size in both our capacity and talent pool."

Will Lewis

CHAIRMAN & CEO, INSMED
"Insmed developed a drug-device combination that became the first approved therapy to treat patients with a refractory form of a rare and serious lung infection."

Anne Pritchett

SENIOR VICE PRESIDENT OF POLICY, RESEARCH AND MEMBERSHIP, PHRMA
"Our organization advocates for public policies that encourage the research and development and manufacturing of new medicines that allow patients to lead longer, healthier, and more productive lives."

Tom Sellig

CEO, ADARE PHARMA SOLUTIONS
"Our reputation is based on how we deploy technologies to solve complex formulation challenges."

Mark Jara

PRINCIPAL AND MANAGING DIRECTOR, RXS
"Tele-health tactics gained momentum and our clients made their pivot, like other industries, to fully remote operations. RxS, with our technology-forward approach, was prepared for the shift."

Candice Long

PRESIDENT – US INFECTIOUS DISEASES & VACCINES, JANSSEN PHARMACEUTICALS
"In vaccines, we are progressing late-stage programs of break-through vaccines against diseases where vaccines are not currently available, such as RSV and multidrug resistant bacterial infections, including ExPEC and Staphylococcus aureus."

Joe Panetta

PRESIDENT & CEO, BIOCOM CALIFORNIA
"We experienced explosive growth across the state and consequently adopted a new name: Biocom California."

John Pennett

PARTNER-IN-CHARGE OF THE NATIONAL TECHNOLOGY AND LIFE SCIENCES GROUP, EISNERAMPER
EisnerAmper speaks about the investment climate for pharma entrepreneurs.

MACIG

SUBSCRIBE TO OUR NEWSLETTER

RECENTLY PUBLISHED

United States Life Sciences 2022

PARTNER EVENTS